Taxol in advanced, hormone‐refractory carcinoma of the prostate. A phase II trial of the eastern cooperative oncology group

Cancer

Volumn 72, Issue 8, 1993, Pages 2457-2460

  Roth, Bruce J ^a   Loehrer, Patrick J ^a   Yeap, Beow Yong ^b   Wilding, George ^c   Kasimis, Basil ^d,f   McLeod, David ^e  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c UNIVERSITY OF WISCONSIN   (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^e WALTER REED ARMY MEDICAL CENTER   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

hormonerefractory; medical oncology; prostate cancer; Taxol

Indexed keywords

ANTIBIOTIC AGENT; CIMETIDINE; CREMOPHOR; DEXAMETHASONE; DIPHENHYDRAMINE; PACLITAXEL; PROSTATE SPECIFIC ANTIGEN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CLINICAL ARTICLE; CONTINUOUS INFUSION; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG MECHANISM; GRANULOCYTOPENIA; HEART INFARCTION; HORMONE RESISTANCE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MALE; MICROTUBULE; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE CARCINOMA; SUDDEN DEATH;

AGED; CASE REPORT; DEATH, SUDDEN, CARDIAC; DRUG RESISTANCE; ESTROGENS; GONADORELIN; HUMAN; LEUKOPENIA; MALE; MIDDLE AGE; MYOCARDIAL INFARCTION; PACLITAXEL; PROSTATIC NEOPLASMS; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL RATE;

EID: 0027486654     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19931015)72:8<2457::AID-CNCR2820720825>3.0.CO;2-Z     Document Type: Article

References (14)

1. Promotion of microtubule assembly in vitro by taxol
2. Taxol‐induced polymerization of purified tubulin: mechanism of action
3. Taxol assembles tubulin in the absence of exogenous guanosine 5′ triphosphate or microtubule‐associated protein
4. Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms
5. Phase II study of taxol in patients with advanced ovarian cancer [abstract]
6. Phase II trial of taxol as second‐line therapy for ovarian carcinoma: a Gynecologic Oncology Group study [abstract]
7. Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer
8. Preliminary results of a phase II trial of estramustine (EMCYT) and vinblastine (VLB) for patients with progressive hormone refractory prostate cancer [abstract]
9. Estramustine and vinblastine: use of prostate specific antigen as a clinical trial end point for hormone refractory prostatic cancer
10. Phase II study of estramustine and vinblastine, two microtubule inhibitors, in hormone‐refractory prostate cancer
11. Taxol blocks processes essential for prostate tumor cell (PC‐3 ML) invasion and metastases
12. Hypersensitivity reactions from taxol
13. Cardiac disturbances during the administration of taxol
14. A reassessment of cardiac toxicity associated with taxol [abstract]